{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["64(8)"],"submitter":["Gordy JT"],"journal":["Antimicrobial agents and chemotherapy"],"pagination":["e00857-20"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7526802"],"repository":["biostudies-literature"],"pubmed_title":["Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste."],"pmcid":["PMC7526802"],"pubmed_authors":["Gordy JT","Dutta NK","Mazumdar K"],"additional_accession":[]},"is_claimable":false,"name":"Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste.","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jul","modification":"2024-11-15T19:41:25.24Z","creation":"2024-11-15T19:41:25.24Z"},"accession":"S-EPMC7526802","cross_references":{"pubmed":["32423954"],"doi":["10.1128/AAC.00857-20","10.1128/aac.00857-20"]}}